Trans patients and TRT access: what the evidence shows

What did @kriswithakanddna actually say?

A nurse practitioner announced she resigned from a Christian-based free clinic she'd volunteered at since 2016, citing two specific policy shifts: the removal of COVID mitigation measures and a new "discriminatory anti-transgender policy." Her decision wasn't impulsive. She described years of inclusive care, then a board change that she says reversed that mission. She also mentioned a patient with brittle diabetes who had finally achieved glycemic control, making the resignation personally painful.

This video is not a medical advice video. It's a personal ethics statement from a clinician. The category flags this under TRT and hormone therapy, which is relevant context, because trans patients receiving hormone therapy, including testosterone for transmasculine patients, are exactly the population an anti-transgender clinic policy would exclude from care.

Does the science back this up?

The clinical harm of denying care to transgender patients is well-documented, and on that point, she's on solid ground. Discrimination at the point of care doesn't just feel bad. It has measurable health consequences.

The 2015 U.S. Transgender Survey (James et al., 2016, National Center for Transgender Equality) found that 33% of transgender patients who saw a provider in the prior year reported a negative experience related to their gender identity, and 23% reported they did not seek needed care due to fear of mistreatment. A 2017 study by Kattari et al. in the journal Sexuality Research and Social Policy found that transgender individuals who experienced healthcare discrimination had significantly worse self-reported health outcomes across multiple domains.

On the COVID mitigation rollback, the CDC and ACIP guidance consistently supported masking and vaccination for vulnerable uninsured populations in clinical settings well into 2023. Removing those protections at a free clinic serving immunocompromised and medically complex patients represents a departure from evidence-based practice, not a return to one.

What did they get wrong (or right)?

She got the core ethics right. A clinician refusing to participate in discriminatory care is not a scandal, it's professional integrity. The American Nurses Association Code of Ethics (2015, provision 1.1) explicitly states that nurses must practice with compassion and respect the dignity of all patients, without prejudice. Nurse practitioners operate under similar standards through the American Association of Nurse Practitioners.

What's harder to fact-check is the characterization of the policy itself. We don't have the clinic's actual policy language, and "discriminatory anti-transgender policy" is her description. That's not a knock on her credibility, it's just the nature of a first-person account. The policy could range from refusing hormone continuation prescriptions to outright refusing care, and those carry different clinical and legal weights in different states.

Her point about "brittle diabetic" patients is clinically real. Continuity of care for patients with poorly controlled diabetes is not optional. A 2019 analysis by Mainous et al. in Family Medicine found that continuity of care is independently associated with better glycemic outcomes in diabetes management. Disrupting that relationship has actual consequences.

What should you actually know?

If you're a trans patient, or a patient receiving testosterone therapy, access to consistent, affirming primary care isn't a luxury, it's a clinical necessity. Hormone therapy requires regular monitoring, including hematocrit, lipid panels, and liver function. A provider change mid-treatment introduces real risk, not just inconvenience.

Free and community clinics serve patients with no other options. When those clinics adopt exclusionary policies, affected patients don't go somewhere else. They often go nowhere. The National Association of Free and Charitable Clinics has published guidance encouraging member organizations to provide care without discrimination, though enforcement is limited since these are nonprofits with autonomous boards.

For patients in this situation, LGBTQ+ health centers and Federally Qualified Health Centers (FQHCs) are required under the Health Center Program to serve all patients regardless of ability to pay, and many have affirming care policies. GLMA (Health Professionals Advancing LGBTQ+ Equality) maintains a provider directory that can help connect patients to affirming primary care.

The broader point she makes, that you learn about a community by how it treats its most vulnerable members, isn't just rhetoric. It's consistent with a significant body of public health literature on structural determinants of health equity.